Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immune Checkpoint Inhibitors
Phase 2
Not yet recruiting
- Conditions
- Cervical NeoplasmsUterine Cervical NeoplasmsCancer of CervixCervical CancerUterine Cervical CancerCancer of the Uterine Cervix
- Interventions
- First Posted Date
- 2023-04-21
- Last Posted Date
- 2023-05-06
- Target Recruit Count
- 58
- Registration Number
- NCT05824494
Association of Gestational Cardiovascular Health With Pregnancy Outcomes
Recruiting
- Conditions
- Pregnant Women
- First Posted Date
- 2023-03-20
- Last Posted Date
- 2023-03-20
- Target Recruit Count
- 5000
- Registration Number
- NCT05776082
- Locations
- 🇨🇳
Women's Hospital School Of Medicine Zhejiang University, Hangzhou, Zhejiang, China
A Cohort Study on Sleep Disorders During Pregnancy
Recruiting
- Conditions
- Sleep Disorder
- Interventions
- Other: No intervention
- First Posted Date
- 2023-03-13
- Last Posted Date
- 2023-03-13
- Target Recruit Count
- 1000
- Registration Number
- NCT05765149
- Locations
- 🇨🇳
Women's Hospital School of Medicine Zhejiang University, Hangzhou, Zhejiang, China
Nab-paclitaxel Versus Sb-taxanes As First-Line Treatment in Advanced Ovarian Cancer
Phase 3
Recruiting
- Conditions
- Epithelial Ovarian Carcinoma Stage IIIEpithelial Ovarian Carcinoma Stage IVFallopian Tube Carcinoma Stage IIIFallopian Tube Carcinoma Stage IVPrimary Peritoneal Carcinoma Stage IIIPrimary Peritoneal Carcinoma Stage IV
- Interventions
- First Posted Date
- 2023-02-21
- Last Posted Date
- 2025-02-11
- Target Recruit Count
- 538
- Registration Number
- NCT05737303
- Locations
- 🇨🇳
The No, 1 People's Hospital of Ningbo, Ningbo, Zhejiang, China
🇨🇳The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
🇨🇳Qilu Hospital of Shandong University, Ji'nan, Shandong, China
Early Prediction of Postpartum Glucose Metabolism Abnormalities in Gestational Diabetes Mellitus
Recruiting
- Conditions
- Gestational Diabetes Mellitus
- Interventions
- Other: Questionnaire survey and specimen collection
- First Posted Date
- 2023-01-04
- Last Posted Date
- 2023-01-04
- Target Recruit Count
- 2000
- Registration Number
- NCT05670548
- Locations
- 🇨🇳
Women's Hospital School Of Medicine Zhejiang University, Hangzhou, Zhejiang, China
A Cohort Study of Hydatidiform Mole
Not yet recruiting
- Conditions
- Hydatidiform Mole
- First Posted Date
- 2022-12-06
- Last Posted Date
- 2022-12-08
- Target Recruit Count
- 800
- Registration Number
- NCT05637892
A Cohort Study of Uterine Malignancies
Recruiting
- Conditions
- Cervical CancerEndometrial Cancer
- First Posted Date
- 2022-12-02
- Last Posted Date
- 2023-10-18
- Target Recruit Count
- 6200
- Registration Number
- NCT05635123
- Locations
- 🇨🇳
Women's hospital school of medicine zhejiang university, Hangzhou, Zhejiang, China
Comparison of Clinical Outcomes in Fresh Cycle With Single Blastocyst Stage and Double Cleavage-stage Embryos: a Single-center, Non-blind, Randomized Controlled Study
Not Applicable
Not yet recruiting
- Conditions
- Infertility, Female
- Interventions
- Procedure: double cleavage-stage or single blastocyst stage embryos transfer
- First Posted Date
- 2022-12-01
- Last Posted Date
- 2022-12-01
- Target Recruit Count
- 1236
- Registration Number
- NCT05632731
Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancer
Not Applicable
Not yet recruiting
- Conditions
- Cytoreductive Surgery
- Interventions
- Other: cytoreductive surgery
- First Posted Date
- 2022-12-01
- Last Posted Date
- 2022-12-01
- Target Recruit Count
- 140
- Registration Number
- NCT05633199
- Locations
- 🇨🇳
Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China
Secondary Cytoreduction Followed by Chemotherapy Versus Chemotherapy Alone in Relapsed Ovarian Cancer After PARPi Maintenance Treatment: a Multicentre, Open-label, Randomised, Phase 3 Trial
Not Applicable
Recruiting
- Conditions
- Relapsed Ovarian Cancer
- Interventions
- Procedure: Secondary cytoreductionDrug: Chemotherapy
- First Posted Date
- 2022-11-07
- Last Posted Date
- 2022-11-07
- Target Recruit Count
- 400
- Registration Number
- NCT05607329
- Locations
- 🇨🇳
Women's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
© Copyright 2025. All Rights Reserved by MedPath